Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04595851 · ClinicalTrials.gov registry record · NA
Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications
A NA study, sponsored by University of Michigan Rogel Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04595851 is a NA study that was terminated before completion, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 6 participants.
The verdict
NCT04595851, a NA study, was terminated before completion, sponsored by University of Michigan Rogel Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The objective of this study is to improve medication, symptom, and disease management of patients with hematological malignancies and multiple chronic conditions (2 or more conditions in addition to cancer) through care coordination between pharmacists working in oncology practices and those working in primary care practices (Pharmacists Coordinated care Oncology Model \[PCOM\]). This is a pilot study in which the investigators will examine the association between outcome measures, but the study design and sample size are insufficient to quantify the impact of OAA initiation or OAA adherence on adherence to chronic medications. This pilot study and data analyses are being done in preparation for a larger, controlled study.
Interventions
- OTHER Patient Reported Outcome Measure (PROM)
- OTHER Comprehensive Medication Review (CMR)
- OTHER Communications between oncology and primary care pharmacists
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-03-26 |
| Est. Completion | 2022-07-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04595851
The ClinicalTrials.gov registry entry for NCT04595851 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Patient Reported Outcome Measure (PROM) is the first listed.
NCT04595851 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04595851 about?
NCT04595851 is a clinical study titled "Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications". The objective of this study is to improve medication, symptom, and disease management of patients with hematological malignancies and multiple chronic conditions (2 or more conditions in addition to cancer) through care coordination between pharmacists working in oncology practices and those working...
What is the current status of trial NCT04595851?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-03-26. Estimated completion is 2022-07-14.
What interventions are being tested in trial NCT04595851?
The interventions under investigation include: Patient Reported Outcome Measure (PROM) (OTHER), Comprehensive Medication Review (CMR) (OTHER), Communications between oncology and primary care pharmacists (OTHER).
Who is sponsoring clinical trial NCT04595851?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.